Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Manfredi

Showing results (201-210 of 248) with videos related to

Pageof 25
Sort By:
Journal of the American Academy of Dermatology|February 28, 2004
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDSLeonardo Calza, Antonietta D'Antuono, Ginevra Marinacci, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2009
Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controlsLeonardo Calza, Daria Pocaterra, Michele Pavoni, et al.
HIV Clinical Trials|May 18, 2012
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitorsLeonardo Calza, Filippo Trapani, Michele Bartoletti, et al.
Infectious Diseases (London, England)|April 16, 2015
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patientsLeonardo Calza, Ilaria Danese, Vincenzo Colangeli, et al.
Onkologie|April 11, 2012
Peritoneal cystic mesothelioma: are surgery and HIPEC optimal first-line treatments?Federico Coccolini, Roberto Manfredi, Fausto Catena, et al.
International Journal of Surgery (London, England)|January 8, 2016
Antibiotic resistance evaluation and clinical analysis of acute appendicitis; report of 1431 consecutive worldwide patients: A cohort studyFederico Coccolini, Giuseppe D'Amico, Massimo Sartelli, et al.
Journal of Clinical Medicine|December 11, 2022
Angina in 2022: Current PerspectivesRoberto Manfredi, Monica Verdoia, Paolo Compagnucci, et al.
International Journal of Surgery (London, England)|July 21, 2015
Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort studyFederico Coccolini, Massimo Sartelli, Fausto Catena, et al.
HIV Clinical Trials|January 6, 2016
Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase InhibitorsLeonardo Calza, Ilaria Danese, Eleonora Magistrelli, et al.
European Journal of Clinical Pharmacology|September 30, 2010
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patientsLeonardo Calza, Laura Mosca, Daria Pocaterra, et al.
Pageof 25

Showing results (201-210 of 248) with videos related to

Sort By:
Pageof 25
Journal of the American Academy of Dermatology|February 28, 2004
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDSLeonardo Calza, Antonietta D'Antuono, Ginevra Marinacci, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2009
Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controlsLeonardo Calza, Daria Pocaterra, Michele Pavoni, et al.
HIV Clinical Trials|May 18, 2012
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitorsLeonardo Calza, Filippo Trapani, Michele Bartoletti, et al.
Infectious Diseases (London, England)|April 16, 2015
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patientsLeonardo Calza, Ilaria Danese, Vincenzo Colangeli, et al.
Onkologie|April 11, 2012
Peritoneal cystic mesothelioma: are surgery and HIPEC optimal first-line treatments?Federico Coccolini, Roberto Manfredi, Fausto Catena, et al.
International Journal of Surgery (London, England)|January 8, 2016
Antibiotic resistance evaluation and clinical analysis of acute appendicitis; report of 1431 consecutive worldwide patients: A cohort studyFederico Coccolini, Giuseppe D'Amico, Massimo Sartelli, et al.
Journal of Clinical Medicine|December 11, 2022
Angina in 2022: Current PerspectivesRoberto Manfredi, Monica Verdoia, Paolo Compagnucci, et al.
International Journal of Surgery (London, England)|July 21, 2015
Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort studyFederico Coccolini, Massimo Sartelli, Fausto Catena, et al.
HIV Clinical Trials|January 6, 2016
Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase InhibitorsLeonardo Calza, Ilaria Danese, Eleonora Magistrelli, et al.
European Journal of Clinical Pharmacology|September 30, 2010
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patientsLeonardo Calza, Laura Mosca, Daria Pocaterra, et al.
Pageof 25